Evidence map›Paper›PMID 28232384›Full record

ArticleMolecular cancer research : MCR2017

The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.

Kuntal Biswas, Sukumar Sarkar, Kangping Du, David L Brautigan, Tarek Abbas, James M Larner

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Multiple functions of p21 in cancer radiotherapy.Journal of cancer research and clinical oncology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. [Role of P21 in Resistance of Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020
    Review
  15. CRISPR/Cas9 for overcoming drug resistance in solid tumors.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kuntal BiswasDepartment of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
Sukumar SarkarDepartment of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
Kangping DuDepartment of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
David L BrautiganCenter for Cell Signaling and Department of Microbiology, Immunology & Cancer Biology, University of Virginia, Charlottesville, Virginia.
Tarek AbbasDepartment of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
James M LarnerDepartment of Radiation Oncology, University of Virginia, Charlottesville, Virginia. jml2p@virginia.edu.
University of Virginia · US

Funding

Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancerR01CA192669 · NCI · UNIVERSITY OF VIRGINIA · PI LARNER, JAMES M · 2015 to 2019
$2.0M
NCI NIH HHS R01 CA192669
6 · The paper itself

Abstract

Lung cancer resists radiotherapy, making it one of the deadliest forms of cancer. Here, we show that human lung cancer cell lines can be rendered sensitive to ionizing radiation (IR) by RNAi knockdown of C-terminus of Hsc70-interacting protein (CHIP/STUB1), a U-box-type E3 ubiquitin ligase that targets a number of stress-induced proteins. Mechanistically, ubiquitin-dependent degradation of the cyclin-dependent kinase (CDK) inhibitor, p21 protein, is reduced by CHIP knockdown, leading to enhanced senescence of cells in response to exposure to IR. Cellular senescence and sensitivity to IR is prevented by CRISPR/Cas9-mediated deletion of the p21 gene (

Indexed as

Cell Line, TumorCRISPR-Cas SystemsCyclin-Dependent Kinase Inhibitor p21Gene Knockdown TechniquesHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansLung NeoplasmsProteolysisRadiation, IonizingRadiation ToleranceUbiquitinationUbiquitin-Protein LigasesCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21HSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsSTUB1 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID28232384
PMCPMC5687089
OpenAlexW2590513734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.